2021
DOI: 10.3390/molecules26144380
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Inflammation by Anthocyanins as the Novel Therapeutic Potential for Chronic Diseases: An Update

Abstract: Low-grade chronic inflammation (LGCI) and oxidative stress act as cooperative and synergistic partners in the pathogenesis of a wide variety of diseases. Polyphenols, including anthocyanins, are involved in regulating the inflammatory state and activating the endogenous antioxidant defenses. Anthocyanins’ effects on inflammatory markers are promising and may have the potential to exert an anti-inflammatory effect in vitro and in vivo. Therefore, translating these research findings into clinical practice would … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(19 citation statements)
references
References 125 publications
(151 reference statements)
0
19
0
Order By: Relevance
“…As reported previously, anthocyanins were recognized as phyto-anti-inflammatory agents [ 39 ], and the role of PSPAs in the anti-inflammatory process has also been confirmed [ 23 ]. However, relative studies have focused on models of chronic noncommunicable diseases, such as cardiovascular diseases and diabetes, and few research has been conducted on acute infection models [ 40 ]. Little research is based on LPS-induced inflammation and even sepsis mouse models, and the contents are limited to phenotype and NF-κB and AP-1 signal transduction pathways.…”
Section: Discussionmentioning
confidence: 99%
“…As reported previously, anthocyanins were recognized as phyto-anti-inflammatory agents [ 39 ], and the role of PSPAs in the anti-inflammatory process has also been confirmed [ 23 ]. However, relative studies have focused on models of chronic noncommunicable diseases, such as cardiovascular diseases and diabetes, and few research has been conducted on acute infection models [ 40 ]. Little research is based on LPS-induced inflammation and even sepsis mouse models, and the contents are limited to phenotype and NF-κB and AP-1 signal transduction pathways.…”
Section: Discussionmentioning
confidence: 99%
“…ACNs are well documented for their antioxidant, antiinflammatory, and anti-apoptotic effects on human health (Henriques et al, 2020;Kozłowska and Dzierżanowski, 2021;Liu et al, 2021;Pérez-Torres et al, 2021;Vega-Galvez et al, 2021). ACNs could be rapidly absorbed in the stomach and detected in the blood and urine (Fang, 2014;Tian et al, 2019), so these pigments are recognized as one of the leading nutraceuticals for prolonging health benefits through the attenuation of chronic, non-communicable diseases, including cancers, obesity, diabetes, cardiovascular diseases, and neurodegenerative diseases.…”
Section: Anthocyanins and Their Biological Effects On Chronic Diseasesmentioning
confidence: 99%
“…The anthocyanins' nature to prevent, ameliorate, and scrub the oxidative stress resulted in them exhibiting biological activities against a number of diseases and physiological malfunctioning [202], that included, besides the cancers, cardiovascular, neurological, diabetic, eye functions of vision [203], obesity, inflammation, analgesic, dysentery, and for wound-wash, which primarily can be considered probably as anti-microbial in nature, although no unambiguous support exists on this aspect till date [22,[204][205][206][207][208]. The beneficial effects of anthocyanins on health has been recorded in several pre-clinical, clinical, and epidemiological studies [43,205,209,210]. However, the purified anthocyanins intake have not shown equivalent effects as the natural mixture of anthocyanins composition as part of fruits, vegetables, and food supplements [211].…”
Section: Anthocyanins-based Broad-spectrum Health Benefitsmentioning
confidence: 99%